Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)

Who can apply

• Small businesses
• Native American tribal organizations (other than Federally recognized tribal governments)
• Private institutions of higher education
• State governments
• County governments
• Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
• Public and State controlled institutions of higher education
• For profit organizations other than small businesses
• City or township governments
• Special district governments
• Public housing authorities/Indian housing authorities
• Independent school districts
• Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
• Native American tribal governments (Federally recognized)
• Foreign Organizations/International Collaborations.

About this grant

This notice of funding opportunity (NOFO) uses a R61/R33 Phased Innovation Award activity code to support clinical research applications that are exploratory and developmental in nature and focus on understanding the neurobiological mechanisms underlying substance use disorders (SUD), including fundamental circuitry and behavior relevant to substance use.